Arrive is an innovative biotechnology company focused on developing therapies for age-related diseases. Utilizing advanced deep learning techniques, it explores complex biological systems to create effective treatments, aiming to improve health and longevity in an aging population.
Specialties
In vivo target discovery
Machine learning integration
Bioinformatics applications
Therapies for age-related diseases
Regenerative health solutions
Products & Services
Therapies for age-related diseases
Deep learning drug discovery
In vivo target screening
Bioinformatics solutions
Preventative health interventions
Contact Information
No contact information available
Competitors & Similar Companies(8)
Calico Life Sciences
California, • United States
Unity Biotechnology
California, • United States
Elysium Health
New York, • United States
Resverlogix Corp
Alberta, • Canada
Rejuvenate Bio
California, • United States • Biotechnology
Sierra Oncology
Millennium Health
California, • United States • Biotechnology
Medication Monitoring, Drug Testing Services, Laboratory Accreditation, Patient Safety Solutions, Treatment Effectiveness Support
Arrive specializes in In vivo target discovery, Machine learning integration, Bioinformatics applications, Therapies for age-related diseases, Regenerative health solutions.
What products and services is Arrive likely to offer?
Arrive offers Therapies for age-related diseases, Deep learning drug discovery, In vivo target screening, Bioinformatics solutions, Preventative health interventions.
Who are the competitors of Arrive?
Competitors of Arrive are Calico Life Sciences, Unity Biotechnology, Elysium Health, Resverlogix Corp, Rejuvenate Bio, Sierra Oncology, Millennium Health, Altos Labs.
What does Arrive do?
Arrive is an innovative biotechnology company focused on developing therapies for age-related diseases. Utilizing advanced deep learning techniques, it explores complex biological systems to create effective treatments, aiming to improve health and longevity in an aging population.